8 employees
Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders.
1997
$7M
from 2 investors over 2 rounds
Solace Therapeutics raised undisclosed on April 1, 2020
Investors: Portfolia
Solace Therapeutics raised $7M on March 28, 2012
Investors: Saints Capital